Previous close | 3.2000 |
Open | 3.2000 |
Bid | 1.1000 |
Ask | 2.8000 |
Strike | 270.00 |
Expiry date | 2024-10-18 |
Day's range | 3.2000 - 3.2000 |
Contract range | N/A |
Volume | |
Open interest | 3 |
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.